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KAJIAN MENGENAI POTENSI RAMBUTAN DAN TEMBIKAI 
DALAM AKTIVITI KEMOPENCEGAHAN KE ATAS SEL 
OSTEOSARKOMA 
 
 
ABSTRAK 
Osteosarkoma adalah kanser malignan ‘kelas pertama’ yang biasanya menyerang 
kanak-kanak dan golongan muda. 85% daripada pesakit masih menghadapi masalah 
metastasis walaupun terdapat kemajuan dalam rawatan seperti kemoterapi dan 
pembedahan. Rawatan kanser menggunakan agen kemopencegahan yang bukan sahaja 
boleh merencat pertumbuhan sel kanser, tetapi juga dengan sasaran yang tepat pada 
peringkat molekular menjadi objektif yang paling penting dalam kajian ini. Tesis ini 
mengkaji potensi buah-buahan yang terdapat di Malaysia, Nephelium lappaceum 
(rambutan) dan Citrullus lanatus (tembikai) terhadap kesan kemopencegahan ke atas sel 
osteosarkoma (CRL 1543). RE dan WE menunjukkan proses perencatan terhadap 
pertumbuhan sel osteosarkoma dan nilai IC50 iaitu 0.005 mg/ml dan 0.5 mg/ml masing-
masing. Proses perencatan sel dikaitkan dengan perencatan kitaran sel dan mencetuskan 
apoptosis. RE dan WE juga menunjukkan perubahan morfologi yang terbentuk melalui 
proses apoptosis. RE dan WE juga telah menyebabkan perencatan kitaran sel masing-
masing pada fasa G2/M dan G0/G1. Pengenalpastian terhadap kebarangkalian terhadap 
laluan isyarat molekular sel penyebab kepada perencatan sel oleh apoptosis dan 
gangguan terhadap kitaran sel telah disiasat dan dikenal pasti laluan isyarat apoptosis 
oleh RE adalah melalui intrinsik melalui pengakrifan terhadap caspase-9 dan caspase-3. 
Manakala WE pula melalui laluan isyarat apoptosis extrinsik melalui pengaktifan 
xvi 
 
caspase-3 tetapi tidak pada caspase-9. Penurunan paras protein antiapoptosis, Bcl2, oleh 
RE dan WE melengkapi penemuan tersebut. Peningkatan paras protein p27
Kip1
 dan 
penurunan paras protein cyclin D1 adalah konsisten dengan penemuan dimana WE 
telah menyebabkan gangguan kitaran sel pada fasa G0/G1. RE pula tidak menyebabkan 
sebarang perubahan terhadap paras protein cyclin D1 yang juga konsisten dengan 
gangguan terhadap fasa G2/M tetapi tidak pada G0/G1. Protein p27
Kip1
 juga telah 
dilaporkan terlibat dalam proses apoptosis konsisten dengan peningkatan paras protein 
p27
Kip1
 oleh RE. RE dan WE didapati tidak toksik terhadap sel normal lantas 
membuktikan bahawa kedua ekstrak ini mempunyai kesan yang baik sebagai 
kemopencegah terhadap CRL 1543. Secara keseluruhannya, data yang terkumpul dari 
tesis ini membuka ruang baru terhadap potensi bahan buangan daripada kulit rambutan 
dan tembikai sebagai agen kemopencegahan terhadap CRL 1543. 
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A STUDY ON THE POTENTIAL OF RAMBUTAN AND 
WATERMELON IN CHEMOPREVENTION ACTIVITY ON 
OSTEOSARCOMA CELL LINES 
 
 
ABSTRACT 
Osteosarcoma is a primary malignant bone tumour that commonly found in children and 
young adults.  Despite of the significant advances of treatment such as chemotherapy 
and surgery were developed against osteosarcoma, 85% of the patients still suffer from 
metastases. The improvement in cancer treatment using cancer chemopreventive agent 
which is not only can inhibit the cancer cells proliferation but with define molecular 
target has become the main objective in this study. This study evaluated the potentiality 
of the Malaysian local fruits, Nephelium lappaceum (rambutan) and Citrullus lanatus 
(watermelon) in exhibiting chemopreventive effects on osteosarcoma cells (CRL 1543). 
RE and WE showed the growth inhibitory effect and with IC50 value at 0.005 mg/ml 
and 0.5 mg/ml respectively. The cell deaths are believed to be associated to the 
induction of apoptosis and cell cycle arrest. Morphological changes displaying 
apoptosis also can be observed upon treatment with RE and WE. Moreover, RE and WE 
also caused alteration to the cell cycle regulation on CRL 1543 at G2/M and G0/G1 
phase respectively. Identification of the possible signalling pathways of cell death by 
apoptosis and cell cycle at molecular level were investigated and the apoptosis 
induction by RE followed an intrinsic via activating caspase-9 and caspase-3. 
Meanwhile, WE induced apoptosis by extrinsic pathway via activating caspase-3 but 
not on caspase-9. The downregulation of antiapoptotic Bcl2 protein expression by RE 
xviii 
 
and WE also complemented the findings. The upregulation of p27
Kip1 
and the 
downregulation of cyclin D1 protein expressions were consistent with the finding of 
WE caused cell cycle arrest at G0/G1 phase. RE otherwise showed no significant 
changes for cyclin D1 protein expression consistent with the G2/M blockage but not in 
G0/G1 phase. p27
Kip1
 has also been reported to induce apoptosis consistent with the 
increased of protein expression of p27
Kip1 
by RE. RE and WE showed no toxicity effect 
on normal cells thus proved the extracts features a potential chemopreventive agent on 
CRL 1543. Overall, the data collected provide new insight of using the waste products 
by rambutan and watermelon rinds which can be used as chemopreventive agents on 
CRL 1543. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Introduction 
Cancer disease is the second of cause death after cardiovascular disease. It has been 
reported that the incidence is over 6 million of cases annually across the globe 
(Srivastava et al., 2005). Although the survival of the patients had increased due to the 
rapid advancement of neoadjuvant chemotherapy and surgery, however, drug resistance 
acquired by cancer cells has led to treatment failure. Factors like rapid emergence of the 
new diseases and the development of the drug resistance have brought to the 
exploration of natural products as alternative strategies for cancer treatment (Cragg et 
al., 1997).  
 
Natural products exist in large diversity in nature and have become the source for 
ameliorate diseases for a long time ago (Graham et al., 2000). Its accumulations also 
have been recorded in the pharmacopeia (Newman et al., 2000). Almost 25 years ago, 
World Health Organization (WHO) estimated that 80% of the people in the developing 
countries, which means around 3.5 to 4 billion of people in the world, rely on plants as 
traditional medicines for their primary health care. To add more, around 85% of it 
involves in plant extracts (Farnsworth, 1988). Recently, the advancement in science and 
technology has brought to the discovery of the commercial drugs and until today, 50% 
of all drugs in clinical use are still represent by natural products (their derivatives and 
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analogs) while another 25% of all drugs comes from higher plant-derived natural 
products (Balandrin, 1993; Raskin & Ripoll, 2004).  
 
Currently, chemoprevention has caught many attentions in the field of scientific 
investigations. Chemoprevention is defined as either suppressing, delaying or reversing 
the carcinogenesis process by using natural product thus served as a new strategy for the 
improvement to the survival rate of patients (Sporn & Suh, 2002). Plants give many 
advantages to human because it is not only included in the dietary consumptions but 
also used as the traditional medicines. Natural product contains several bioactive plant 
compounds that are also the product of metabolism, in which their function in life 
processes acts a similar way to the compounds that operate in human and animals 
(Ameenah, 2006). These bioactive plant compounds are including plant polyphenols 
which has been reported to display antiproliferative and cytotoxicity effect to several 
tumors but not on normal cells (Denise et al., 1996; Georgine et al., 1997). Besides that, 
an ideal chemopreventive agent should display a significant bioavailability, safety, 
inexpensive and can target on more than one mechanism of actions. Thus, dietary 
consumption of foods and herbal medicines is a convenient method of administering 
potentially chemopreventive agents in a cost-effective manner. 
 
The mechanism of cancer cell death induced by bioactive compounds from natural 
product is one of the approaches for chemopreventive activity. The chemopreventive 
agents have the ability to block or delay the promotion or progression of pre-malignant 
or malignant cells by modulating cell proliferation or differentiation (Sun et al., 2004). 
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Thus, the alteration on the cellular signalling pathways such as on apoptotic cell death 
and disturbation on cell cycle regulations by chemopreventive agents can provide 
information in natural drug discovery (Fulda & Debatin, 2006; Khan et al., 2009; 
Vermeulen et al., 2003).  
 
Apoptosis, a form of programmed cell death, plays a critical role in both development 
and tissue homeostasis and it can be characterised by morphological and biochemical 
hallmarks, including cell shrinkage, nuclear DNA fragmentation and membrane 
blebbing (Hengartner, 2000). Activation of apoptosis signalling pathway is the key 
point by chemopreventive agents in cancer chemoprevention and defects in apoptosis 
signalling pathways will lead to the tumour resistance (Debatin, 2004). It is resulted by 
the activation caspases, a family of cysteine proteases that act as common death effector 
molecules in various forms of cell death (Degterev et al., 2003; Fulda & Debatin, 2006). 
Thus, a better understanding of this mode of tumour cell death by chemopreventive 
agents will provide a molecular basis for new strategies targeting caspase-dependent 
and independent death pathways.  
 
On the other hand, cell cycle regulation in normal cells will control and maintain 
homeostasis within cells by determining whether a cell will continue to proliferate, 
enter into a quiescent state or undergo apoptosis (Foster, 2008). The cell cycle 
regulation in normal cells is tightly controlled by checkpoints and any malfunction in 
this regulation is believed to be one of the hallmarks for cancer. It is regulated by the 
action of cyclin-dependent kinases (CDKs) that will form a complex with a regulatory 
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cyclin protein and will be activated at specific points in the cell cycle (Devault et al., 
1992; Schafer, 1998). The cell cycle consists of four phases (G1, S, G2 and M) and the 
alterations on these phases in cell cycle regulations can become activated due to many 
factors such as DNA damage, defects during replication of DNA or due to the 
exogenous stress signals (Gabrielli et al., 2012; Vermeulen et al., 2003). This will bring 
to the development of tumour cells. Thus, another approach of chemoprevention is by 
targeting the signal signalling pathways related to the cell cycle events by 
chemopreventive agents in tumour cells either at G1, S or G2/M phase that will 
eventually induce apoptotic cell death to the tumour cells (Sarkar & Li, 2004).  
 
Rambutan (Nephelium lappaceum) and watermelon (Citrullus lanatus) rinds are 
basically inedible due to its lack of taste and were treated as agriculture by-product. 
However, studies have shown that both rinds hold potential bioactive compounds. 
According to Palanisamy et al., 2008, rambutan contains polyphenolic compound that 
possess the antioxidant capacity. Watermelon also has been reported to possess a small 
amount of polyphenolic compound and a low amount of vitamin C when compared to 
other fruits (Gil et al., 2006). Epidemiology studies have also reported that watermelon 
contains lycopene which is an antioxidant compound from member of carotenoid family 
can decrease risk of various cancers such as lung, prostate and colon cancer (Cai et al., 
2004; Giovannucci, 1999; Rao & Agarwal, 1998). The antioxidant compound has the 
ability to scavenge of free radicals and thus inhibit oxidation reactions (Jacob et al., 
2008). The overproduction of free radicals in human‟s body might lead to the oxidative 
damage of biomolecules such as proteins, DNA or lipid, that eventually leads to chronic 
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diseases such as atherosclerosis, aging, diabetes and including cancer (Barry, 1994; 
Steinmetz & Potter, 1996). Therefore, the mechanism of tumour cell death by apoptosis 
and deregulation of cell cycle related to these bioactive compounds from rambutan and 
watermelon in human system are worth to be studied for the development of new 
chemopreventive agents and to our best knowledge, no studies have been done on 
rambutan and watermelon rinds on osteosarcoma or known as bone cancer either in 
vitro or in vivo. 
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1.2 Problem statement 
Cancer is a major health problem in Malaysia. According to Penang Cancer Registry in 
1994, it is reported that the age standardised incidence rate for all cancers in Malaysia 
was 115.9 per 100 000 for males and 119.7 per 100 000 for females and it is expected to 
rise with an increase in aging population. In 1998, Malaysia‟s population was 21.4 
million, of whom 4% were aged 65 years and above. The incidence of cancer is 
expected to rise with an increase in aging population. In 1957, the proportion aged of 
more than 60 years was 4.6%, had increased to 5.7% in 1990 and it is projected to be 
9.8% in 2020 (Karim, 1997). Currently, the treatment for cancers are varies. It includes 
surgery, radiotherapy, chemotherapy and hormonal therapy. However, the conventional 
treatment does not show an improvement and the prognosis of cancer is still poor. Thus 
the new therapeutic approach is seriously needed to improve the quality of health of the 
patients.  
 
Therefore, chemoprevention can be the most reliable treatment nowadays because it 
uses natural product to either suppress, delaying or reversing the process of 
carcinogenesis. By understanding the mechanism of cell death and targeting the cell 
signalling pathways involving apoptosis and cell cycle in tumour cells will give 
important information in cancer chemoprevention. This has given the idea to consult a 
research involving the comparative chemopreventive effect between rambutan 
(Nephelium lappaceum) and watermelon (Citrullus lanatus) rind extracts in order to see 
the potentialities of rambutan and watermenon as chemopreventive agents on human 
osteosarcoma cancer cell lines.  
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1.3 Research objectives 
The main idea of this research is to get a better understanding on chemopreventive 
effect of rambutan and watermelon on human osteosarcoma cancer cell lines at 
molecular level. In order to achieve the main idea of the research, there are few specific 
objectives need to be outlined. 
 
i. To determine the inhibitory concentration 50% (IC50) and its antiproliferative 
effect of rambutan and watermelon rind extracts on human osteosarcoma cancer 
cell lines. 
ii. To observe any morphological changes upon treatment with rambutan and 
watermelon rind extracts on human osteosarcoma cancer cell lines. 
iii. To investigate the effect of rambutan and watermelon rind extracts on apoptosis 
on human osteosarcoma cancer cell lines.  
iv. To investigate the effect of rambutan and watermelon rind extracts on cell cycle 
regulation on human osteosarcoma cancer cell lines. 
v. To investigate the effect of rambutan and watermelon rind extracts on apoptosis 
markers such as caspases, MAPK (mitogen-activated protein kinase) and Bcl2 
proteins and cell cycle proteins such as cyclin D1 and p27Kip1.    
vi. To determine the cytotoxicity effect of rambutan and watermelon extracts on 
normal osteoblast (NHOst) cell lines. 
 
The flowchart of the experimental design carried out in this study is shown in 
APPENDIX A 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Cancer 
Cancer disease is a second of natural cause of death after cardiovascular disease where 
the incidence are over 6 million of cases has been reported annually across the globe 
(Srivastava et al., 2005). Cancer is always defined simply as the uncontrolled 
proliferation of abnormal cells. Although it is correct, but this is actually a very general 
definition that does not explain its extremely complex process where it also involves 
pathological state of cancer. The multifunctional and dynamic molecular event of 
cancer processes requires the changing effect of neoplastic cells and its interaction with 
their surrounding stroma and also with the immune system (Carbone & Pass, 2004). 
Cancer in general is characterised by two main characteristics. Firstly, it has an 
uncontrolled cells growth that eventually form a new growth, known as tumour or 
neoplasm. Secondly, the cells can migrate from original site to distant site and develops 
into another type of tumour tissues by spreading to other organs, resulting in metastasis. 
However, Hanahan and Weinberg, (2000) had characterised cancer by the following six 
hallmarks as in Figure 2.1.  
 
Cancer is caused by many factors contributing to the disease by which environmental 
factors and endogenous factors are the examples that may contribute to the cancer 
initiation and development. In general, tumour occurs when the cell divides excessively 
in the body. Typically, neoplasm occurs when the cell division is uncontrollable and  
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Figure 2.1: Hallmarks of carcinogenesis. The complex process by which normal cells 
will turn into malignant tumour including i) it has enough capability to stimulate growth 
signals, ii) it is insensitive to growth inhibitory signals, iii) potentially to proliferates 
uncontrollable, iv) angiogenesis process is sustained, v) as the ability to evade the 
apoptosis and vi) tendency to invade surrounding tissue and travel beyond the site of 
origin (Hanahan & Weinberg, 2000). 
 
 
 
 
 
 
10 
 
unbalanced (Bhadauria et al., 2012). Since cell division requires in the biological 
activity where it replace the older cells that is damaged or dysfunctional to new 
functional cells in balance, if the cell division and death is disturbed, a tumour may 
form. Tumour varies to the normal cells because they differ in many aspects such as in 
the growth control, morphology, cell-to-cell interactions, membrane properties, 
cytoskeletal structure, protein secretion and gene expression (Joyce & Pollard, 2009).  
However, tumour can be cancerous (malignant) or non-cancerous (benign). The 
processes of which the normal cells turn into cancer cells are called carcinogenesis. 
 
2.1.1 Pathogenesis of cancer 
Cancer can be resulted from the complex process of carcinogenesis where it involves a 
series of individual steps upon activation of protooncogenes and tumour suppressor 
genes. They can be divided into three distinct molecular and cellular alteration stages, 
which are initiation (normal cell becomes transformed or initiated cell), followed by 
promotion (initiated cell become preneoplastic cell) and later the progression 
(preneoplastic cell become neoplastic cell) stage. The process of carcinogenesis is 
summarised in Figure 2.2. 
 
The process of carcinogenesis begins with initiation process which resulted from rapid 
and irreparable process which includes normal cells that exposed to any carcinogenic 
agents. The metabolic activation has distributed it to organs and tissues thus 
subsequently interact covalently with target cell DNA, leading to the genotixic damage 
that remains unrepaired or misrepaired. These transformed cells will undergo many  
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Figure 2.2: Schematic representation of multi-stage carcinogenesis. These process 
involved steps from initiation, promotion and later by progression process (adapted and 
modified from Annelyse et al., 2005). 
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changes to form preneoplastic cells (Young-Joon, 1999). The initiation process 
however, is not rapid as compared to initiation process. It is the expansion of damage 
cells to actively proliferate and in this stage, oxidative stress and chronic inflammatory 
become the key point in promoting tumour proliferation and angiogenesis that are 
necessary for tumour growth (Coussens & Werb, 2002). 
 
While the last stage of carcinogenesis which is the progression, involves gradual 
production of the new clones of tumour cells and conversion of tumour cells into 
invasive cells, thus leading to increase of its metastasis potential (Pan et al., 2011). This 
progression process (angiogenesis/invasion/metastasis) involves rate-limiting steps that 
are influenced by non-malignant cells of the tumour microenvironment (Figure 2.3).  
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Figure 2.3: The primary tumour microenvironment. The tumour microenvironment 
comprises of a numerous cells such as the endothelial cells of blood and lymphatic 
circulation, stromal fibroblasts and a variety of bone marrow-derived cells including 
macrophages, myeloid-derived suppressor cells, TIE2-expressing monocytes and 
mesenchymal stem cells (adapted from Joyce & Pollard, 2009). 
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2.2 Osteosarcoma (human bone cancer) 
Osteosarcoma is a common primary malignant bone tumour that is commonly known as 
childhood diseases. However, osteosarcoma can continue throughout adulthood (Figure 
2.4). It arises from primitive bone-forming mesenchymal cell that histopathologically 
shows osteoid formation (Schajowicz et al., 1995). Only 5% of osteosarcoma occurs in 
jaws (Rosen et al., 1982) and craniofacial osteosarcoma that often located in the 
mandible or maxilla (Vege et al., 1991; Wanebo et al., 1992) accounts only 6-13% of 
all osteosarcomas (Caron et al., 1971; Clark et al., 1983; Garrington et al., 1967) and 
often located in the mandible or maxilla. Osteosarcoma in jaws is rare, but more 
aggressive malignancy compared to osteosarcoma of the long bones. Both types of 
osteosarcoma differ in its biological behaviours, but share the same histologic features. 
Classical osteosarcoma of long bones most often affects adolescents and young adult 
meanwhile craniofacial osteosarcoma typically occurs in the third or fourth decade of 
life (Bertoni et al., 1991; Caron et al., 1971; Clark et al., 1983; Delgado et al., 1994; 
Mark et al., 1991). 
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Figure 2.4: Age-related incidence of osteosarcoma (adapted and modified from Clark et 
al., 1983). 
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2.2.1 Symptoms and treatment for osteosarcoma 
Patients with craniofacial osteosarcoma may have the symptoms such as changes in the 
fit of dental prosthesis, the teeth become loose or changes in tooth position. The signs 
and symptoms of craniofacial osteosarcoma are also including regional swelling, pain 
and paraesthesia (Clark et al., 1983). However, these signs and symptoms are non 
specific, thus there is often a delay before correct diagnosis can be made (August et al., 
1997; Patel et al., 2002). Due to poor prognosis in patients with osteosarcoma, it is very 
important to find other alternative ways in order to treat the patients with osteosarcoma. 
Metastasis also common and occurs within 1 to 2 years and it remains the primary cause 
of poor survival for patients with osteosarcoma. Chemotherapy followed by surgery 
becomes the only method of treatment for patients with this disease (Link et al., 1986; 
Trieb et al., 2003; Valabrega et al., 2005). However, surgery is also associated with 
lower survival rate meanwhile chemotherapy does not improve the cancer prognosis. 
Otherwise, early diagnosis and radical surgery are the better ways to improve survival 
rate. Although the prognosis of craniofacial osteosarcoma is poorer than osteosarcoma 
in long bones, research on the combination of adjuvant therapy and radical surgery need 
to be improved (Mardinger et al., 2001). This is due to the combination of surgery and 
aggressive adjuvant chemotherapy did improved the overall survival for patients with 
osteosarcoma, however, more than 90% of the patients with osteosarcoma and 30-4-% 
patients with non metastatic disease still experience relapse after the treatment (Goorin 
et al., 1991; Link et al., 1986). 
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2.3 Natural products for cancer treatment 
Plant kingdom provides a great source of medicine since the beginning of human 
civilisation and during that time, plants have become dominant in treating ailment and 
diseases. The earliest written document of medicinal plants for various illnesses has 
been recorded in at least 4000 years ago to the Sumerians (Jin-Ming et al., 2003).  The 
ancient civilisations of the Chinese, Indians and North Africans also provide written 
evidences for the use of natural sources for curing various diseases (Phillipson, 2001). 
For instance, raw garlic was prescribed for circulatory disorders, mandrake was 
prescribed for pain relief and tumeric possesses blood clotting properties and these 
traditional remedies are still being used until now (Phillipson, 2001). However, in the 
nineteenth century, the isolating and purifying compounds from natural sources alone 
rather than accepting the medicinal power of the crude extracts has started to become 
famous (McCurdy & Scully, 2005). Taxol (Paclitaxel), camptothecin, morphine and 
quinine are the examples of drugs derived from active components isolated from natural 
sources (Phillipson, 2001). Morphine has been isolated from Papaver somniferum while 
atropine is obtained from Atropa belladonna meanwhile Taxol is obtained from the 
stem bark of Taxus brevifolia (Western yew). Taxol has brought interest to the scientists 
since it showed potent anti-leukemia and anti-tumor properties in cell assays (Wani et 
al., 1971). Between the years 1981-2006, about a hundred anticancer agents have been 
developed, of which, twenty five are natural product derivatives, eighteen are natural 
product mimics, eleven candidates are derived from a natural product pharmacophore, 
and nine are pure natural products (Newman & Cragg, 2007). Thus natural sources 
make a very significant contribution to the health care system. 
18 
 
2.3.1 Secondary metabolites 
Secondary metabolites are actually a generic name for over 30,000 different substances 
that can be produced by plants. Secondary metabolites have a lot of purposes and 
functions to the plant such as in giving colour to the plants, protecting the plant from the 
pest, as plant‟s own hormones as well as can act as attractants. Since these active 
secondary metabolites have given a great impact to human health, it has been noted to 
be prescribed in drugs and it is known that 25% of all drugs come from natural products 
(Raskin & Ripoll, 2004). Secondary metabolites do not have nutrient characteristic to 
human they exist in a small amount in the human body. However, their effect in human 
health is actually enormous and many of these effects are not well known and required a 
lot of investigations. The wide variety of bioactive compounds and nutrients in fruit and 
vegetables has been hypothesised to have the ability in inhibiting three stages of 
carcinogenesis; initiation, promotion, and progression. These bioactive compounds have 
been prove in preventing cancer development by affecting cell cycle regulation and 
progression, inhibit the activation of pro-carcinogens, quench exogenous and 
endogenous radicals, stimulating the immune system, and also modulating hormone 
metabolism (Smith-Warner et al., 2006). Figure 2.5 summarises the structural classes of 
pharmacologically active secondary metabolites from plants such as phenolics 
compound, terpenoids and steroids (Schmidt et al., 2007). 
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Figure 2.5: Classification of pharmacologically active secondary metabolites (adapted 
from Schmidt et al., 2007). 
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2.4 Cancer chemoprevention 
Currently, the conventional treatments have failed to exert control of the metastasis. 
Chemoprevention is a very attractive strategy which uses natural products in either 
suppress, delay or reverses the process of carcinogenesis (Sporn, 1976). The close 
relationship between dietary intake with their benefits in „life-style-related-diseases‟ 
such as cancer and heart disease has been proven for decades. According to Williams, 
1995, fruit juices possess health benefits that are associated with inhibiting certain 
cancers and heart disease. Moreover, according to epidemiological studies, the regular 
consumption of fruits and vegetables might provide health benefits due to their natural 
compounds such as carotenoids, flavonoids, phenolic compounds and vitamins 
(Gardner et al., 2000).  
 
Compounds with diverse structural and chemical components are always associated 
with reducing the risk of cancer. For instance, Vitamin C, E and β-carotenes are well 
known as powerful antioxidant properties (Krinsky & Johnson, 2005). However, instead 
of these antioxidant properties, phenolics and polyphenolics, which also known as 
secondary metabolites acts as a better scavenger of free radicals compared to vitamin C 
and E (Shi et al., 2003). Thus, the mechanism of chemopreventive effect by these 
phytochemicals at molecular level is one of the promising approaches of cancer 
chemoprevention. The identification of new chemopreventive agents is still lacking and 
further investigation is needed since Malaysia is a great source of plant kingdom 
(Murakami et al., 2000). 
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2.4.1 Mechanisms of chemoprevention 
2.4.1.1 Apoptosis 
Around 10 billion of cells die in each day in order to give ways to new cells arising 
through mitosis. This process is needed to maintain the homeostatic balance of the 
body. Apoptosis that also known as programmed cell death (PCD) was firstly reported 
in 1964 by Gewies and Grimm, (2003). It is a vital process in this life-death cycle. 
Apoptosis is necessary for the elimination of pathogen infected cells from the body, as 
well as activated- or auto aggressive immune cells (Heemels, 2000). It is a physiological 
process of removing the dead or damaged cells effectively during development which 
cannot be repaired during the cell cycle (Gewies & Grimm, 2003; Kerr et al., 1972). 
Failure of these cells to be eliminated through apoptosis may lead to their 
immortalisation and possible malignancy (Evan & Littlewood, 1998). The word 
„apoptosis‟ is from Greek word which means „falling off or dropping off‟ in analogy of 
petals dropping off from a flower or leaves falling off from trees. This term „apoptosis‟ 
emphasising that the death of living matter is a necessary part of the life cycle in 
organisms. Since apoptosis is a pathway that all cells possess to death, thus, defects in 
apoptosis pathway and the ability for the cells to evade death is one of the hallmarks of 
cancer (Okada & Mak, 2004).  
 
The understanding of apoptosis plays an important role in the study of physiological 
process in cancer research, for instance, the mutation of p53 gene has been significant 
with the production of defective proteins that can be found in cancer cells that resulted 
in resistance to the apoptosis (Debatin, 2004). The resistance of cancer cells towards 
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therapeutic agents therefore, has brought to the new research focusing on devising ways 
to overcome this resistance and thus subsequently triggers apoptosis (Okada & Mak, 
2004). The ability of p53 to induce apoptosis is a crucial defence against cancer where 
apoptosis is also a key to immune defence and elimination of cancerous cells (Yu, 
2006). The activation of apoptosis pathway leads to the suicidal cell by characteristic 
processes that the dead cells will ultimately fragmented and engulfed by cells such as 
macrophages (Figure 2.6). 
 
2.4.1.1.1 Morphology features of apoptosis and necrosis 
Unlike necrosis, apoptosis produce some fragments called apoptotic bodies that 
phagocytic cells are able to engulf the damage cells. Necrosis otherwise is a traumatic 
but passive form of cell death resulting to the released of cellular contents into the 
surrounding environment, resulting to the damage to the surrounding cells and causes a 
strong inflammatory response in the corresponding tissues (Gewies, 2003). Apoptosis is 
characterised by the biochemical hallmarks and distinct morphology such as cell 
shrinkage, membrane blebbing, or deformation of the cells and loosen contact with the 
neighbouring cells. The apoptotic bodies otherwise contain cytosol, organelles and 
condensed chromatin (Okada & Mak, 2004). The DNA ladder with multiple fragments 
caused by internucleosomal DNA cleavage will be ending up by being engulfed by 
macrophages or other neighbouring cells to avoid the inflammatory response to 
surrounding tissues (Savill & Fadok, 2000).  
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Figure 2.6: Hallmarks of the apoptotic and necrotic cell death process. Necrosis occurs 
when the cells are exposed to the physical or chemical disturbance resulting in the loss 
of membrane integrity, thus causing the cells to swell and rupture. Otherwise apoptosis 
is characterised by the biochemical hallmarks and distinct morphology such as cell 
shrinkage, membrane blebbing, or deformation of the cells and loosen contact with the 
neighbouring cells (adapted from Gewies, 2003). 
 
 
 
 
24 
 
2.4.1.2 Mechanism of apoptosis pathway 
Apoptosis signal transduction can be divided into two pathways by which the intrinsic 
or mitochondria-mediated apoptosis and also the extrinsic or receptor linked apoptosis 
that occurs when the death receptor on the surface is triggered. Although these 
pathways initiated through different mechanisms but they seem to converge at the 
activation of pro-caspase 3, that will subsequently activates other pro-caspases along the 
caspase pathway that ultimately leads to apoptosis of the cell. Targeting apoptosis 
pathway is one of the important mechanisms for treatment regimes in order to kill 
tumour cells. Anticancer therapies are always associated with the activation of caspases, 
a family of cysteine-aspartic acid proteases. The biochemistry of apoptosis is 
summarised in three stages, the activation of initiator caspases, mitochondrial release of 
„apoptogens‟ and finally the activation of effector caspases, which cleave recognised 
substrates to dismantle the dying cell (Yoshida et al., 2003).  
 
The activation of mitochondrial-dependent (intrinsic) pathway of apoptosis can be via 
loss of growth factor due to the response or signals such as chemotherapeutics drugs, 
DNA damage, oxidative stress or hypoxia. During apoptosis, various stimuli disturbed 
the membrane permeability of mitochondria and subsequently proteins in the 
mitochondrial intermembrane space are released into the cytoplasm. The protein is 
known as apotegenic factor which including cytochrome c, apoptosis-inducing factor 
(AIF), Smac/Diablo, Omi/HtrA2, endonuclease G, caspase-2 or caspase-9 (Debatin, 
2004; Yoshida et al., 2003). 
